Study shows St. John’s wort ineffective on ADHD
KENMORE, Wash. A study published in the Journal of the American Medical Association has shown that St. John’s wort is no more effective than a placebo at treating attention-deficit hyperactivity disorder, also known as ADHD.
Researchers gave St. John’s wort and placebo pills to 54 children aged 6 to 17 in the Seattle area. The children’s ADHD symptoms did not improve significantly.
Bastyr University, in Kenmore, Wash., led the study. Researchers from the University of Washington and Seattle’s Children’s Hospital & Regional Medical Center also participated.
Leiner recalls lots of Liquimax multivitamin
CARSON, Calif. Leiner Health Products, recently acquired by NBTY, last week announced that it is recalling its 32-ounce plastic bottles of Liquimax Complete Nutrition Multivitamin Formula, labeled with UPC Code 7497052290, 7497023607 or 7497023696, because the product may contain undeclared fish (not shellfish), tree nuts (almonds, pecans and/or walnuts), and wheat.
People who have allergies to fish, tree nuts and/or wheat run the risk of serious or life-threatening allergic reaction if they consume these products, the company stated.
The recalled Liquimax Multivitamin was distributed nationwide in retail stores.
The company had been made aware of the presence of these allergens after receiving consumer reports of an allergic reaction.
AMO addresses contact lens safety for FDA’s opthalmic panel
SANTA ANA, Calif. In an Advanced Medical Optics presentation before the Food and Drug Administration’s Ophthalmic Devices Panel of the Medical Devices Advisory Committee on Tuesday, the company addressed several general issues regarding the safety and effectiveness of contact lens solutions and demonstrated that infection control is a complex issue that involves more than the formulation of the solution itself.
“Rub and rinse has been proven to improve effectiveness against Acanthamoeba and other microorganisms,” stated David Hansen, director of professional services, AMO. “We firmly believe that it should be an integral part of an effective contact lens hygiene regimen.”
The company, which manufactures the Complete brand of eye care products, also shared information on ways to minimize the risk of infections such as Acanthamoeba keratitis among people who wear contact lenses and underscored the importance of proper handling, disinfection and hygiene when using contact lenses and contact lens products.
The company also addressed the FDA’s interest in evaluating preclinical microbiology test methods to better serve as predictors of real world product performance. AMO supports establishing standards for testing the effectiveness of contact lens solutions in effectively disinfecting against a broad range of organisms in the best interest of the patients who use its products. “We look forward to collaborating with the FDA on the most effective and appropriate path forward because we share their interest in controlling infections,” said Trenary. “Per our routine policy, we will comply with new FDA standards and/or labeling decisions and take any requested actions within the allotted timeframe.”